Stock Report

Indo US Bio-Tech Ltd Q3 FY2025-26 net profit lower at Rs. 2.99 crore

Posted On : 2026-01-21 19:38:41( TIMEZONE : IST )

Indo Us Bio-Tech Ltd has reported Standalone financial results for the period ended December 31, 2025.

Financial Results (Q3 FY2026) - QoQ Comparison

The company has reported total income of Rs. 22.8033 crores during the period ended December 31, 2025 as compared to Rs. 30.8727 crores during the period ended September 30, 2025.

The company has posted net profit / (loss) of Rs. 2.9966 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs. 3.4521 crores for the period ended September 30, 2025.

The company has reported EPS of Rs. 1.49 for the period ended December 31, 2025 as compared to Rs. 1.72 for the period ended September 30, 2025.

Financials	Q3 FY2026	Q2 FY2026	% Change
Total Income	₹22.8033 crs	₹30.8727 crs	-26.14%
Net Profit	₹2.9966 crs	₹3.4521 crs	-13.19%
EPS	₹1.49	₹1.72	-13.37%

Financial Results (Q3 FY2026) - YoY Comparison

The company has reported total income of Rs.22.8033 crores during the period ended December 31, 2025 as compared to Rs.23.5827 crores during the period ended December 31, 2024.

The company has posted net profit / (loss) of Rs.2.9966 crores for the period ended December 31, 2025 as against net profit / (loss) of Rs.5.0545 crores for the period ended December 31, 2024.

The company has reported EPS of Rs.1.49 for the period ended December 31, 2025 as compared to Rs.2.52 for the period ended December 31, 2024.

Financials	Q3 FY2026	Q3 FY2025	% Change
Total Income	₹22.8033 crs	₹23.5827 crs	-3.30%
Net Profit	₹2.9966 crs	₹5.0545 crs	-40.71%
EPS	₹1.49	₹2.52	-40.87%

Financial Results (9 Months Ended FY2026) - YoY Comparison

The company has reported total income of Rs.84.4471 crores during the 9 Months period ended December 31, 2025 as compared to Rs.70.5163 crores during the 9 Months period ended December 31, 2024.

The company has posted net profit / (loss) of Rs.11.1511 crores for the 9 Months period ended December 31, 2025 as against net profit / (loss) of Rs.12.5828 crores for the 9 Months period ended December 31, 2024.

The company has reported EPS of Rs.5.56 for the 9 Months period ended December 31, 2025 as compared to Rs.6.28 for the 9 Months period ended December 31, 2024.

Financials	9 Months Ended FY2026	9 Months Ended FY2025	% Change
Total Income	₹84.4471 crs	₹70.5163 crs	19.76%
Net Profit	₹11.1511 crs	₹12.5828 crs	-11.38%
EPS	₹5.56	₹6.28	-11.46%

Shares of Indo Us Bio-Tech Ltd was last trading in BSE at Rs. 112.10 as compared to the previous close of Rs. 107.25. The total number of shares traded during the day was 19463 in over 486 trades.

The stock hit an intraday high of Rs. 114.50 and intraday low of 105.40. The net turnover during the day was Rs. 2156707.00.